The historical rank and industry rank for Ganga Pharmaceuticals's Pretax Margin % or its related term are showing as below:
BOM:539680'
s Pretax Margin % Range Over the Past 10 Years
Min: 1.58 Med: 3.55 Max: 8.29
Current: 4.57
BOM:539680's Pretax Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 7.285
vs BOM:539680: 4.57
Ganga Pharmaceuticals (BOM:539680) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Ganga Pharmaceuticals Pretax Margin % Related Terms
Ganga Pharmaceuticals Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Ganga Pharmaceuticals's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ganga Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ganga Pharmaceuticals Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ganga Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Ganga Pharmaceuticals's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ganga Pharmaceuticals (BOM:539680) has a Pretax Margin % of 6.56% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ganga Pharmaceuticals and its competitors. This is 85% above median its historical median of 3.55. Over the past decade, Ganga Pharmaceuticals' Pretax Margin % has ranged from 1.58 to 8.29.
Is Ganga Pharmaceuticals' Pretax Margin % too high?
Ganga Pharmaceuticals' current Pretax Margin % of 6.56% is 85% above median its 10-year median of 3.55. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 8.29. The Drug Manufacturers industry median Pretax Margin % is 7.29. Ganga Pharmaceuticals' value of 6.56% is 10% below this industry median. Overall, Ganga Pharmaceuticals has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ganga Pharmaceuticals' Pretax Margin % compare to ZTS?
Ganga Pharmaceuticals' Pretax Margin % of 6.56% can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.29. Ganga Pharmaceuticals' value of 6.56% is 10% below this benchmark. Historically, Ganga Pharmaceuticals' own Pretax Margin % has ranged from 1.58 to 8.29 over the past decade. While the company's 10-year median is 3.55 vs. the industry median of 7.29, Ganga Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ganga Pharmaceuticals's current Pretax Margin % of 6.56% is 10% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ganga Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ganga Pharmaceuticals's current Pretax Margin % is 6.56%, which is 85% above median its own 10-year median of 3.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ganga Pharmaceuticals stock overvalued right now?
Ganga Pharmaceuticals (BOM:539680) has a current Pretax Margin % of 6.56%. The stock's GF Value™ is ₹11.85, compared to a current price of ₹12.00 — trading 1.3% above its estimated fair value. The current Pretax Margin % is 6.56%, which is 85% above median its 10-year median of 3.55 and 10% below the Drug Manufacturers industry median of 7.29. Ganga Pharmaceuticals' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ganga Pharmaceuticals (BOM:539680), the current Pretax Margin % is 6.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ganga Pharmaceuticals (BOM:539680) Overvalued in 2026?
Based on GuruFocus' analysis, Ganga Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹12.00 is trading 1.3% above its estimated GF Value™ of ₹11.85.
Key valuation signals for BOM:539680:
Pretax Margin %: 6.56% (85% above median its 10-year median of 3.55)
GF Value™: ₹11.85 vs. price of ₹12.00 (1.3% above fair value)
Industry Position: 10% below the Drug Manufacturers median
No single metric tells the full story. See the BOM:539680 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.
62GF Score
Get the complete analysis for BOM:539680
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539680 has been successfully added to your 
